一种用于克服非小细胞肺癌治疗中抗原异质性的多靶向 CAR-T 细胞平台
A Multi-Targeting Chimeric Antigen Receptor-T Cell Platform to Overcome Antigen Heterogeneity in the Treatment of Non-Small Cell Lung Cancer.
这些发现支持采用多靶点CAR-T 策略来应对NSCLC及可能其他实体瘤中的抗原异质性。
CELL INTELLIGENCE · 肿瘤细胞治疗研究
肿瘤细胞治疗研究
英文原题:A Pragmatic Machine Learning Approach to Quantify Tumor-Infiltrating Lymphocytes in Whole Slide Images.
A Pragmatic Machine Learning Approach to Quantify Tumor-Infiltrating Lymphocytes in Whole Slide Images.
分数与星级只用于站内排序 —— 不代表疗效、安全性或个人适用性。
多种癌症中TIL(肿瘤浸润淋巴细胞)水平升高提示预后较佳。病理医师手动计数免疫细胞既耗时又不准确。本研究旨在利用计算方法,自动定量肺癌患者标准苏木精-伊红(H&E)诊断切片中的TIL。研究将一种开源机器学习方法迁移至TIL定量任务。该方法原本使用公共数据训练,用于H&E切片细胞核分割和分类;本研究在不进行人工数据标注的情况下应用该方法。
结果显示,自动TIL定量与患者预后相关,且表现优于当前非小细胞肺癌免疫细胞检测先进方法:现行标准为DAB染色组织芯片中CD8细胞,风险比(HR)0.34(95%置信区间0.17–0.68);本研究H&E全切片中的HoVer-Net PanNuke Aug模型HR为0.30(95%置信区间0.15–0.60),HoVer-Net MoNuSAC Aug模型HR为0.27(95%置信区间0.14–0.53)。该方法有助于衔接机器学习研究、转化临床研究和临床应用。但在临床实施前仍需进一步验证。
Increased levels of tumor-infiltrating lymphocytes (TILs) indicate favorable outcomes in many types of cancer. The manual quantification of immune cells is inaccurate and time-consuming for pathologists.
Our aim is to leverage a computational solution to automatically quantify TILs in standard diagnostic hematoxylin and eosin-stained sections (H&E slides) from lung cancer patients.
Our approach is to transfer an open-source machine learning method for the segmentation and classification of nuclei in H&E slides trained on public data to TIL quantification without manual labeling of the data.
Our results show that the resulting TIL quantification correlates to the patient prognosis and compares favorably to the current state-of-the-art method for immune cell detection in non-small cell lung cancer (current standard CD8 cells in DAB-stained TMAs HR 0. 34, 95% CI 0. 17-0. 68 vs. TILs in HE WSIs: HoVer-Net PanNuke Aug Model HR 0. 30, 95% CI 0. 15-0. 60 and HoVer-Net MoNuSAC Aug model HR 0. 27, 95% CI 0. 14-0. 53).
Our approach bridges the gap between machine learning research, translational clinical research and clinical implementation.
However, further validation is warranted before implementation in a clinical setting.
在 PubMed 查看 → 出版商原文(DOI) 全文 PDF(PMC)· 可下载 治疗专题与资料阅读指南 资料来源与翻译说明 报告译文或资料问题 →
MEMBER ACCOUNT
登录成功会直接打开下一页。